American Strategic Investment (NYC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
2025 Annual Meeting of Stockholders scheduled for May 29, 2025, to be held virtually at 2:00 p.m. Eastern Time.
Stockholders are encouraged to review proxy materials online and vote electronically or request paper copies if preferred.
Meeting access and voting instructions provided, with emphasis on the importance of shareholder participation.
Voting matters and shareholder proposals
Election of one Class II director, Elizabeth K. Tuppeny, to serve until the 2028 Annual Meeting.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2025.
Advisory vote on executive compensation (say-on-pay) included as a non-binding resolution.
Board recommends voting "FOR" all three main proposals.
Other matters may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Board recommends the election of a single director nominee for a three-year term.
Latest events from American Strategic Investment
- $91.9M net loss on $84.7M impairment, $63.5M sale pending, EBITDA and occupancy up.NYC
Q2 20241 Feb 2026 - Q3 net loss rose on impairments; 9 Times Square sale to cut leverage and boost diversification.NYC
Q3 202414 Jan 2026 - Net loss narrowed in Q4 2024 as asset sales improved leverage and a new CEO was appointed.NYC
Q4 202424 Dec 2025 - Annual meeting to vote on director, auditor, and say-on-pay, with all proposals recommended for approval.NYC
Proxy Filing1 Dec 2025 - Revenue and NOI fell, losses widened, but occupancy rose and liquidity risks remain.NYC
Q1 202526 Nov 2025 - Revenue fell, losses narrowed, and liquidity risks rose as asset sales and foreclosures continued.NYC
Q2 202523 Nov 2025 - Q3 2025 delivered $35.8M net income, stable occupancy, and ongoing liquidity and listing risks.NYC
Q3 202520 Nov 2025